Eupraxia Pharmaceuticals ...

NASDAQ: EPRX · Real-Time Price · USD
5.32
0.04 (0.76%)
At close: Aug 15, 2025, 3:49 PM
5.30
-0.43%
After-hours: Aug 15, 2025, 04:55 PM EDT

Eupraxia Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a 2.98M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a 57.51K 50.46K 1.49M 49.91K 49.19K 48.62K 55.12K 49.89K 48.9K 39.37K 41.41K 29.57K 20.31K 20.24K
Gross Profit
n/a n/a n/a -57.51K -50.46K 1.49M -49.91K -49.19K -48.62K -55.12K -49.89K -48.9K -39.37K -41.41K -29.57K -20.31K -20.24K
Operating Income
-7.12M -7.48M -6.27M -6.56M -9.03M -6.35M -8.62M -7.44M -4.85M -8.57M -4.68M -6.03M -3.36M -3.41M -5.04M -5.29M -7.13M
Interest Income
309.45K 218.01K 304.34K 401.23K 236.37K 177.76K 193.88K 152.27K 163.03K 169.39K 140.82K 88.57K 28.28K 24.92K 15.01K 11.88K 80.00
Pretax Income
-6.76M -7.53M -5.99M -8.3M -8.3M -4.31M -6.55M -8M -5.04M -9.08M -4.79M -6.28M -3.76M -3.78M -5.14M -5.6M -8.86M
Net Income
-6.76M -7.51M -5.94M -6.01M -8.15M -4.1M -6.31M -7.83M -4.96M -8.82M -4.66M -6.09M -3.69M -3.72M -4.97M -5.44M -8.86M
Selling & General & Admin
3.27M 3.6M 2.22M 2.58M 3.38M -199.46K 2.59M 2.84M 1.26M 2.25M 966K 1.18M 1.41M 1.57M 1.48M 1.33M 4.51M
Research & Development
3.85M 3.88M 4.05M 3.97M 5.6M 6.87M 6.1M 4.68M 2.97M 6.49M 3.85M 4.91M 1.95M 1.83M 3.56M 3.63M 669.7K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
7.12M 7.48M 6.27M 6.56M 8.98M 6.53M 8.88M 7.65M 4.8M 8.8M 4.87M 6.14M 3.39M 3.44M 5.06M 4.98M 5.2M
Interest Expense
n/a 137.00 451.00 281.85K 321.14K 255.8K 320.47K 301.77K 291.48K 347.93K 249.96K 286.84K 268K 264.18K 253.98K 148.53K 358.17K
Selling & Marketing Expenses
n/a n/a n/a n/a 859.81K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.12M 7.48M 6.27M 6.56M 9.03M 6.53M 8.88M 7.65M 4.85M 8.8M 4.87M 6.14M 3.39M 3.44M 5.06M 4.98M 5.2M
Income Tax Expense
2.79K 1.8K n/a -5K 6.74K -291.45K n/a 389.68K -82.34K n/a n/a n/a n/a n/a n/a n/a -1.49M
Shares Outstanding (Basic)
35.69M 35.62M 35.62M 35.62M 28.81M 27.31M 25.52M 22.01M 21.7M 21.59M 21.39M 19.9M 14.24M 12.41M 14.24M 13.23M 13.05M
Shares Outstanding (Diluted)
35.69M 35.62M 35.62M 35.62M 28.81M 27.31M 25.52M 22.01M 21.7M 21.59M 21.39M 19.9M 14.24M 12.41M 14.24M 13.23M 13.05M
EPS (Basic)
-0.21 -0.21 -0.17 -0.17 -0.28 -0.15 -0.25 -0.36 -0.23 -0.41 -0.22 -0.31 -0.26 -0.3 -0.35 -0.41 -0.68
EPS (Diluted)
-0.21 -0.21 -0.17 -0.17 -0.28 -0.15 -0.25 -0.36 -0.23 -0.41 -0.22 -0.31 -0.26 -0.3 -0.35 -0.41 -0.68
EBITDA
-6.72M -7.48M -5.95M -5.75M -8.98M -10.52M -6.07M -7.4M -4.8M -8.52M -4.63M -5.98M -3.32M -2.64M -5.01M -5.27M -7.11M
EBIT
-6.76M -7.53M -5.99M -5.79M -7.86M -10.57M -4.5M -9.2M -4.54M -6.43M -3.69M -4.59M -2.74M -2.7M -3.77M -4.36M -6.66M
Depreciation & Amortization
46.49K 54.51K 37.76K 42.03K 50.46K 7.82K 49.91K 49.19K 48.62K 55.12K 49.89K 48.9K 39.37K 41.41K 29.57K 20.31K 20.24K